Nu-Med Plus (NUMD) Enterprise Value Growth (1y) (2012 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | Nu-Med Plus | - | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 72.14% |
| Sep 30, 2025 | 51.79% |
| Jun 30, 2025 | 78.64% |
| Mar 31, 2025 | 62.67% |
| Dec 31, 2024 | 65.13% |
| Sep 30, 2024 | 63.56% |
| Jun 30, 2024 | 86.51% |
| Mar 31, 2024 | 88.01% |
| Dec 31, 2023 | 90.70% |
| Sep 30, 2023 | -1,665.61% |
| Mar 31, 2023 | -1,990.22% |
| Dec 31, 2022 | -526.94% |
| Sep 30, 2022 | 98.03% |
| Mar 31, 2022 | 98.18% |
| Dec 31, 2021 | 93.81% |
| Sep 30, 2021 | -1.09% |
| Jun 30, 2021 | -1,092.78% |
| Mar 31, 2021 | -659.85% |
| Dec 31, 2020 | -2,562.89% |
| Sep 30, 2020 | 24.71% |
| Jun 30, 2020 | 61.07% |
| Mar 31, 2020 | 21.26% |
| Dec 31, 2019 | 95.77% |
| Sep 30, 2019 | 75.14% |
| Jun 30, 2019 | 94.56% |
| Mar 31, 2019 | 91.55% |
| Dec 31, 2018 | 52.28% |
| Sep 30, 2018 | 58.89% |
| Jun 30, 2018 | -9.43% |
| Mar 31, 2018 | 12.72% |
| Dec 31, 2017 | -2,719.62% |
| Sep 30, 2017 | -29,496.02% |
| Jun 30, 2017 | -596.62% |
| Mar 31, 2017 | -260.05% |
| Dec 31, 2016 | 59.71% |
| Sep 30, 2016 | -555.45% |
| Jun 30, 2016 | -253.30% |
| Mar 31, 2016 | -575.14% |
| Dec 31, 2015 | 45.08% |
| Sep 30, 2015 | 99.63% |
| Jun 30, 2015 | 72.80% |
| Mar 31, 2015 | -67.50% |
| Dec 31, 2014 | -325.36% |
| Sep 30, 2014 | -574.79% |
| Jun 30, 2014 | -377.17% |
| Mar 31, 2014 | -108.56% |
| Dec 31, 2013 | -1,709.71% |
| Sep 30, 2013 | -4,407.57% |
| Jun 30, 2013 | 51.31% |
| Mar 31, 2013 | 93.69% |
| Dec 31, 2012 | 15.98% |